CalciMedica
CALC
26 hedge funds and large institutions have $5.97M invested in CalciMedica in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 3 closing their positions.
2,400% more call options, than puts
Call options by funds: $75K | Put options by funds: $3K
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
8% more funds holding
Funds holding: 24 → 26 (+2)
41% less capital invested
Capital invested by funds: $10.2M → $5.97M (-$4.2M)
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Belvedere Trading
Chicago,
Illinois
|
+$4.26K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$4.15K |
| 3 |
Morgan Stanley
New York
|
+$1.12K |
| 4 |
NA
NewEdge Advisors
New Orleans,
Louisiana
|
+$785 |
| 5 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
+$505 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$35.6K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$17.7K |
| 3 |
First Manhattan
New York
|
-$16.5K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$14.7K |
| 5 |
Jane Street
New York
|
-$11K |
CALC Hedge Fund Activity: Q4 2022 in Review
26 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in CalciMedica (CALC) for Q4 2022, worth a combined $5.97M — down 41% from $10.2M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new CALC positions and 3 closed out — a net gain of 2 holders — while 4 added to existing stakes and 7 trimmed.
The largest buyer was Belvedere Trading, opening a new position worth an estimated $4.26K. The largest seller was Renaissance Technologies, cutting an estimated $35.6K.
- 26 institutional investors held CalciMedica (CALC) as of Q4 2022, up from 24 in Q3 2022.
- Funds reported $5.97M of CalciMedica stock for Q4 2022, down 41% quarter-over-quarter.
- 5 funds opened new CalciMedica positions in Q4 2022 and 3 closed out, a net change of +2 holders.
- The largest CalciMedica buyer in Q4 2022 was Belvedere Trading, an estimated $4.26K added.
- The largest CalciMedica seller in Q4 2022 was Renaissance Technologies, an estimated $35.6K sold.
Based on aggregated 13F filings for Q4 2022.